MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco Pharmaceuticals ETF (NY:PJP)

102.74 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 102.74
Bid (Size) 97.19 (100)
Ask (Size) 108.93 (100)
Prev. Close 102.74
Today's Range 102.74 - 102.74
52wk Range 72.25 - 110.81
Shares Outstanding 28,900
Dividend Yield 0.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint. 
Via Stocktwits
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
According to a Wall Street Journal report, the drugmaker said it will reorganize its human health segment into two separate units in an effort to better position its portfolio for the years ahead. 
Via Stocktwits
Topics Intellectual Property

Performance

YTD
-1.6%
-1.6%
1 Month
-5.8%
-5.8%
3 Month
-2.5%
-2.5%
6 Month
+9.7%
+9.7%
1 Year
+21.6%
+21.6%

More News

Read More
News headline image
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗
Via Stocktwits
Topics ETFs Government
News headline image
Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗
Via Stocktwits
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided ↗
Via Stocktwits
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
Via Stocktwits
Topics World Trade
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Via Benzinga
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
Via Benzinga
News headline image
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗
Via Benzinga
News headline image
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗
Via Benzinga
Topics Government World Trade
News headline image
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗
Via Stocktwits
Topics Government
News headline image
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗
Via Benzinga
News headline image
FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗
Via Stocktwits
News headline image
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion ↗
Via Benzinga
Topics Government
News headline image
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' ↗
Via Benzinga
Topics Government
News headline image
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report ↗
Via Stocktwits
Topics Government Intellectual Property Lawsuit
News headline image
Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗
Via Benzinga
Topics Government
News headline image
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗
Via Benzinga
Topics Government World Trade
News headline image
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' ↗
Via Benzinga
Topics Government
News headline image
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗
Via Benzinga
Topics ETFs
News headline image
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch ↗
Via Benzinga
News headline image
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits ↗
Via Benzinga
Topics Bankruptcy Lawsuit
News headline image
A Look At Pharma ETFs Post Q1 Earnings ↗
Via Talk Markets
Topics ETFs

Frequently Asked Questions

Is Invesco Pharmaceuticals ETF publicly traded?
Yes, Invesco Pharmaceuticals ETF is publicly traded.
What exchange does Invesco Pharmaceuticals ETF trade on?
Invesco Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Pharmaceuticals ETF?
The ticker symbol for Invesco Pharmaceuticals ETF is PJP on the New York Stock Exchange
What is the current price of Invesco Pharmaceuticals ETF?
The current price of Invesco Pharmaceuticals ETF is 102.74
When was Invesco Pharmaceuticals ETF last traded?
The last trade of Invesco Pharmaceuticals ETF was at 03/12/26 08:00 PM ET
What is the market capitalization of Invesco Pharmaceuticals ETF?
The market capitalization of Invesco Pharmaceuticals ETF is 2.97M
How many shares of Invesco Pharmaceuticals ETF are outstanding?
Invesco Pharmaceuticals ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story